Development of broadly applicable combinatorial genome editing and antisense therapies for Duchenne muscular dystrophy addressing dystrophin deficiency, muscle wasting and muscle fibrosis

Project: Research

StatusFinished
Effective start/end date1/10/1530/09/16

Funding

Muscular Dystrophy UK: £74,900

ID: 25862669